Evidence map›Paper›PMID 29882062›Full record

ReviewCurrent infectious disease reports2018

Comparative Study of Molecular Approaches for the Detection of Influenza Virus from Patient Samples Using Real-time PCR: Prospective Disease Burden Study in Kerala (India) from 2010 to 2016.

Seetha Dayakar, Heera R Pillai, Vineetha P Thulasi, Devakikutty Jayalekshmi, Radhakrishnan R Nair

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current infectious disease reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Seetha DayakarLaboratory Medicine and Molecular Diagnostics, Rajiv Gandhi Center for Biotechnology, Bio-Innovation Center (BIC), KINFRA Film & Video Park, Thiruvananthapuram, Kerala, 695585, India.
Heera R PillaiSrinivasa Ramanujan Institute for Basic Sciences, Rajiv Gandhi Centre for Biotechnology, Bio-Innovation Center (BIC), KINFRA Film & Video Park, Thiruvananthapuram, Kerala, 695585, India.
Vineetha P ThulasiLaboratory Medicine and Molecular Diagnostics, Rajiv Gandhi Center for Biotechnology, Bio-Innovation Center (BIC), KINFRA Film & Video Park, Thiruvananthapuram, Kerala, 695585, India.
Devakikutty JayalekshmiLaboratory Medicine and Molecular Diagnostics, Rajiv Gandhi Center for Biotechnology, Bio-Innovation Center (BIC), KINFRA Film & Video Park, Thiruvananthapuram, Kerala, 695585, India.
Radhakrishnan R NairLaboratory Medicine and Molecular Diagnostics, Rajiv Gandhi Center for Biotechnology, Bio-Innovation Center (BIC), KINFRA Film & Video Park, Thiruvananthapuram, Kerala, 695585, India. radhakrishnan@rgcb.res.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewAcute respiratory infections caused by influenza virus are a major cause of viral respiratory diseases globally. Surveillance of circulating subtypes and estimation of disease burden is of utmost clinical importance. Molecular surveillance and proper disease burden estimates are scarce in India although clinical influenza infections are on the rise. Our study aims to delineate the prevalent influenza subtypes in a South Indian population from cases requiring hospital visits. Using real-time polymerase chain reaction (RT-PCR), 2154 throat/nasopharyngeal swabs from patients attending Government Medical College, Thiruvananthapuram, Kerala, India, with suspected influenza-like illness, were tested for the presence of different influenza subtypes. RESEARCH

findingsForty-three percent of specimens were positive for the influenza virus. Among these, prevalence of influenza A(H3N2), influenza B, and H1N1pdm09 was 26.7, 6.3, and 10%, respectively. Nominal co-infections were detected. An easy to use commercial kit was used for the majority of the study after proper evaluation for sensitivity and specificity against a gold standard protocol. Specific diagnosis using molecular tools caters to the urgency, and a precise measure of the disease burden and management actions are needed, especially in developing countries like India. Infection rate estimation using a sensitive RT-PCR assay signified that influenza was highly prevalent in the region. The study data generated will help understand the epidemiology of influenza in India as well as generate information for global influenza surveillance and disease burden.

Indexed as

Acute respiratory infectionsInfluenza disease burdenInfluenza virus

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.